Conditions: Generalized Anxiety Disorder
Keywords: Generalized Anxiety Disorder GAD
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 680
Healthy volunteers: no

Brief summary:
The purpose of this study is to evaluate the efficacy, safety and tolerability of vilazodone relative to placebo in the treatment of generalized anxiety disorder (GAD)

Detailed description:

Arms:
arm 1: Dose-matched placebo one per day, oral administration arm 2: Vilazodone 20mg once per day, oral administration. arm 3: Vilazodone 40mg once per day, oral administration

Interventions: intervention 1: Placebo intervention 2: Vilazodone intervention 3: Vilazodone
Intervention descriptions: intervention 1: Matching 10 mg and 20 mg placebo tablets, once per day, oral administration, intervention 2: Vilazodone, 20mg, oral administration once per day. intervention 3: Vilazodone, 40mg, oral administration once per day.

Protocol document: